Carisoprodol, Aspirin and Codeine Phosphate
- Product NDC
- 64980-176
- 11-digit product format
- 649800176
- Labeler code
- 64980
- Product ID
- 64980-176_0a84d3a6-8506-4cbb-9705-2b81ba79a09a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carisoprodol, Aspirin and Codeine Phosphate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals, Inc.
- Application
- ANDA040860
- Marketing category
- ANDA
- Marketing start
- 2018-03-12
- Marketing end
- 2020-01-31
- Substance
- CARISOPRODOL; ASPIRIN; CODEINE PHOSPHATE
- Active strength
- 200 mg/1; mg/1; mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record